UroGen Pharma
URGN
URGN
139 hedge funds and large institutions have $460M invested in UroGen Pharma in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 48 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.31% more ownership
Funds ownership: 85.96% → 90.27% (+4.3%)
1% more funds holding
Funds holding: 138 → 139 (+1)
6% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 48
Holders
139
Holding in Top 10
6
Calls
$1.71M
Puts
$542K
Top Buyers
| 1 | +$35.5M | |
| 2 | +$33M | |
| 3 | +$5.78M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.87M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$3.4M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$3.19M | |
| 3 | -$2.93M | |
| 4 |
Millennium Management
New York
|
-$2.46M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.34M |
